Filgotinib shows improvements in rheumatoid arthritis trial - Drug Development Technology
Filgotinib shows improvements in rheumatoid arthritis trial Drug Development Technology
An international Phase III trial has demonstrated that Gilead's filgotinib led to improvements in rheumatoid arthritis patients.
Comments
Post a Comment